<p>Tumour-bearing animals underwent surgical biopsy (pre-treatment) followed by a period of recovery before each was treated with 30mg/kg dacomitinib to inhibit EGFR. After 2 hours, a second biopsy was performed (post-treatment). Immunohistochemical detection of phosphorylated EGFR (Y1068, brown) in cryosections of biopsied tumours demonstrates that EGFR phosphorylation was significantly reduced after treatment with dacomitinib (lower row).Four representative mice are shown (#735, #736, #765 and #768). Sections were counterstained with haematoxylin (blue). Scale bar represents 100μm.</p
<p>(A) Antitumor activity of FGFR inhibitor, TKI258. Daily oral administration of TKI258 at 50 mg/kg...
Phosphorylation of tyrosine residues on the epidermal growth factor (EGF) receptor (EGFr) is an impo...
<p>EGFR and phosphorylated EGFR protein abundances in rat cortex tissue of control rats (<i>Ctrl</i>...
Biopsy is often used to investigate brain tumour-specific abnormalities so that treatments can be ap...
<div><p>Biopsy is often used to investigate brain tumour-specific abnormalities so that treatments c...
<p>Cells were cultured to log-phase and treated with 100 nM dacomitinib or 100 ug/mL cetuximab for 1...
<p>(<b>A</b>, <b>B</b>) Female Balb/c mice (n = 4) bearing 4T1 tumours were treated with 40 mg/kg of...
<p>(5a) Tumor growth inhibition in mice. MDA-MB-468 subcutaneous breast tumors treated systemically ...
<p>FaDu, UT-SCC-8, and UT-SCC-42a cells were treated with Dacomitinib (D; 0, 10, 50, 100, 250, or 50...
<p>(A) FaDu-bearing mice were randomized to: (i) DMSO control; (ii) Dacomitinib (5 mg/kg/d) delivere...
<p>Cells were cultured to log-phase and treated with 100 nM dacomitinib, 100 nM erlotinib or 100 ug/...
<p>Cells were cultured to log-phase and treated with 100 nM dacomitinib or 100 ug/mL cetuximab for 1...
<p><b>A</b> Analysis of the total phosphorylation of EGFR. MDA-MB-468 cells were treated with 3 nM, ...
<p>Cells were stimulated with EGF for the indicated durations (<b>A</b>) or with various doses of EG...
<p>(A) SCID mice-bearing H1975/Vec- or H1975/HGF- tumors were administered WZ4002 (25 mg/kg) and/or ...
<p>(A) Antitumor activity of FGFR inhibitor, TKI258. Daily oral administration of TKI258 at 50 mg/kg...
Phosphorylation of tyrosine residues on the epidermal growth factor (EGF) receptor (EGFr) is an impo...
<p>EGFR and phosphorylated EGFR protein abundances in rat cortex tissue of control rats (<i>Ctrl</i>...
Biopsy is often used to investigate brain tumour-specific abnormalities so that treatments can be ap...
<div><p>Biopsy is often used to investigate brain tumour-specific abnormalities so that treatments c...
<p>Cells were cultured to log-phase and treated with 100 nM dacomitinib or 100 ug/mL cetuximab for 1...
<p>(<b>A</b>, <b>B</b>) Female Balb/c mice (n = 4) bearing 4T1 tumours were treated with 40 mg/kg of...
<p>(5a) Tumor growth inhibition in mice. MDA-MB-468 subcutaneous breast tumors treated systemically ...
<p>FaDu, UT-SCC-8, and UT-SCC-42a cells were treated with Dacomitinib (D; 0, 10, 50, 100, 250, or 50...
<p>(A) FaDu-bearing mice were randomized to: (i) DMSO control; (ii) Dacomitinib (5 mg/kg/d) delivere...
<p>Cells were cultured to log-phase and treated with 100 nM dacomitinib, 100 nM erlotinib or 100 ug/...
<p>Cells were cultured to log-phase and treated with 100 nM dacomitinib or 100 ug/mL cetuximab for 1...
<p><b>A</b> Analysis of the total phosphorylation of EGFR. MDA-MB-468 cells were treated with 3 nM, ...
<p>Cells were stimulated with EGF for the indicated durations (<b>A</b>) or with various doses of EG...
<p>(A) SCID mice-bearing H1975/Vec- or H1975/HGF- tumors were administered WZ4002 (25 mg/kg) and/or ...
<p>(A) Antitumor activity of FGFR inhibitor, TKI258. Daily oral administration of TKI258 at 50 mg/kg...
Phosphorylation of tyrosine residues on the epidermal growth factor (EGF) receptor (EGFr) is an impo...
<p>EGFR and phosphorylated EGFR protein abundances in rat cortex tissue of control rats (<i>Ctrl</i>...